老年高血压药物治疗进展  

Research on antihypertensive drug in the treatment of elderly patients

作　　者：黄桂梅[1] 

机构地区：[1]武汉市汉口医院医保科,湖北武汉430000

出　　处：《中国医药导报》2011年第13期13-15,27,共4页China Medical Herald

摘　　要：高血压是冠心病、慢性心力衰竭、房颤和脑卒中等疾病的高危发病因子,在老年人群中的发生率高达2/3。噻嗪类利尿剂、钙拮抗剂、血管紧张素转换酶抑制剂、血管紧张素受体抑制剂和β受体阻滞剂等5类药物均能有效控制高血压并减少其不良后果,但各有其治疗优势。应重视多药治疗对老年高血压患者的安全性、依从性和经济负担所造成的不利影响。Hypertension affects two-thirds of elderly and remains a potent risk factor for coronary artery disease,chronic heart failure,atrial fibrillation and stroke in this age group.Numerous trials have demonstrated reduction in these adverse outcomes with antihypertensive drugs that including Thiazide-type Diuretics,Calcium-channel Blockers,Angiotensin-converting-enzyme Inhibitors,Angiotensin-receptor Blockers and β-adrenergic blockers.The use of multiple medications has major implications in the elderly in terms of medication costs,adherence,and the risk of adverse drug reactions.

关 键 词：抗高血压药 老年患者 多药治疗 

分 类 号：R972.4[医药卫生—药品]